4th Annual Conference on Psychedelics and Psychedelic Medicine
We invite you to join us at the Westin Copley Place in Boston for our 4th Annual Conference on Psychedelics and Psychedelic Medicine conference.
Please Note: The conference will be held in Eastern Daylight Time (EDT)
This conference will provide up-to-date overviews and discussions of advances in the field of psychedelics and psychedelic-assisted therapies, with an emphasis on clinical studies and practice. Mechanisms of action including pharmacology, neuroscience, and psychodynamic theory will be discussed, with a focus on specific clinical entities such as depression, PTSD, and addictions. Additional panel discussions and presentations will explore history, ethics, cultural issues, plant medicine, and many other relevant topics within the rapidly growing field of psychedelic medicine.
Why Attend?
- Gain Knowledge, Insight, and Comprehension: Keep abreast of the latest developments in psychedelics and psychedelic-assisted therapies, focusing on clinical research and practical applications.
- Connect and Build Relationships: Engage with peers and specialists in the psychedelics industry, fostering networking opportunities and collaborations throughout the conference and beyond.
- Stay Current and Informed: Expand your understanding of the dynamic field of psychedelic medicine by participating in panel discussions and presentations that cover a wide range of topics, including history, ethics, culture, plant medicine, and other pertinent issues.
Can't attend in person? Register for 2024 Virtual Psychedelics
Pricing
MDs/Doctoral-Level Professionals
Regular Registration $750.00
Other Clinicians
Regular Registration $675.00
Other professionals, trainees, or students
$150.00
Ticketed Lunch Seminar (Optional):
Building a Psychedelic Assisted Therapy Practice - November 16, 2024
$115.00
PRINTED SYLLABUS - Printed syllabus sales have closed and are no longer available for purchase.
E-SYLLABUS
We provide all attendees with completely free access to all slide presentations in digital PDF format prior to the conference. This is an environmentally friendly alternative and helps keep costs lower for all attendees. The e-syllabus will be available for 30 days after the conference.
Cancellation Policy
A refund minus a $100.00 administrative fee will be issued for refund requests received by October 2, 2024. No refunds will be issued for refund requests made after October 2, 2024. Payments made may not be applied to future conferences or other educational activities. There are no exceptions to these policies.
Target Audience
This program is designed for clinicians and researchers across various disciplines who are interested in deepening their understanding of psychedelics, both theoretically and practically. It is open to mental health practitioners such as psychiatrists, psychiatric nurse practitioners, social workers, and clinical psychologists, as well as professionals from other fields who are curious about the applications of psychedelics in clinical and research settings.
Accreditation
In support of improving patient care, MGH Institute of Health Professions is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
15.0 Physicians
MGH Institute of Health Professions designates this live activity for a maximum of 15.0 AMA PRA Category 1 Credits ™. Physicians should claim only credit commensurate with the extent of their participation in this activity.
15.0 Nursing Contact Hours
MGH Institute of Health Professions designates this activity for 15.0 contact hours for nurses.
15.0 Social Workers
As a Jointly Accredited Organization, MGH Institute of Health Professions is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. MGH Institute of Health Professions maintains responsibility for this course. Social workers completing this course receive 15.0 clock hours for continuing education credits.
15.0 IPCE Credit
As a Jointly Accredited Organization, MGH Institute of Health Professions is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. MGH Institute of Health Professions maintains responsibility for this course. Social workers completing this course receive 15.0 clock hours for continuing education credits.
Learning Objectives
By the end of this program, participants will be able to:
- Compare different models of psychedelic-assisted psychotherapy (eg, psycholytic vs psychedelic)
- Explain the neuropsychopharmacology of classical psychedelics as well as atypical psychedelics such as ketamine and empathogens such as MDMA
- Identify hypotheses for mechanisms of action of psychedelics on the brain, based on recent neuroimaging studies
- Critique contemporary medico-cultural issues within psychedelic research, including race-based structural biases and epistemic injustice
- Assess potential applications of psychedelic-assisted therapy in extra-psychiatric fields, such as within palliative care and spirituality, as well as within medicine, such as for pain and immunomodulation
4th Annual Conference on Psychedelics & Psychedelic Medicine
Program Agenda
November 15-16, 2024
Day 1 – November 15, 2024
8:00-8:05 AM Welcome and Introduction
Franklin King, MD
MODULE TOPIC 1: Background, Pharmacology, & Keynote
8:05–8:30 AM A Brief History of Psychedelics
Franklin King, MD
8:30-8:55 AM Pharmacology
Franklin King, MD
8:55-9:40 AM The Psychedelic Mainstreaming Train Temporarily Derailed
Rick Doblin, PhD
9:40-9:55 AM Question & Answer
Moderator: Jerrold F. Rosenbaum, MD
Discussant: Rick Doblin, PhD
9:55-10:10 AM Break
MODULE TOPIC 2: Risks, Harms and Conceptual Challenges
10:10-10:35 AM From Efficacy to Effectiveness: Towards Reliable Evidence-Based Policy for Psychedelic Therapies
Eduardo Schenberg, PhD
10:35-11:00 AM Risks and Harms in Psychedelics and Psychedelic-Assisted Therapies
Alden Doerner Rinaldi, MD
11:00-11:25 AM A Theological Reckoning with Bad Trips: A Patient’s Perspective
Tristan Angieri, MArch, MTS Candidate
11:25-11:55 AM Panel Discussion
Moderator: Franklin King, MD
Panelists: Rachel Peterson, MD, Alden Doerner Rinaldi, MD, Eduardo Schenberg, PhD.
11:55-12:55 PM Lunch Break (on your own)
MODULE TOPIC 3: Psychedelics & Psychosomatics
12:55-1:25 PM Psychedelic-Assisted Therapies and Serious Medical Illness
Roxanne Sholevar, MD, Zachary Sager, MD, Yvan Beaussant, MD
1:25-1:50 PM Psilocybin in Functional Medical Disorders: A Pilot Study in Irritable Bowel Syndrome
Erin Mauney, MD; Franklin King, MD
1:50-2:20 PM Panel Discussion
Moderator: Jerrold F. Rosenbaum, MD
Panelists: Erin Mauney, MD, Roxanne Sholevar, MD, Zachary Sager, MD, Yvan Beaussant, MD, Franklin King, MD
MODULE TOPIC 4: Psychedelic-Assisted Psychotherapy
2:20-2:45 PM Reflections from Psychedelic-Assisted Psychotherapy Using Ketamine and MDMA
Elizabeth Call, PhD
2:45-3:10 PM What’s Therapy Got to Do With It?
Michael Alpert, MD
3:10-3:35 PM Music and Your Mind: Approach to Music in Psychedelic Therapy Sessions
Lisa Summer, PhD
3:35-4:05 PM Panel Discussion
Moderator: Franklin King, MD
Panelists: Elizabeth Call, PhD, Michael Alpert, MD, Lisa Summer, PhD
4:05-4:15 PM Break
4:15 – 5:15PM Friday Breakout Seminars:
The Neurobiology of Plant Medicine: Leveraging 21st Century Approaches to Ethnobotany
Stephen Haggarty, PhD
Psychedelics and Psychosis: Phenomenological Differences and Overlaps
Haley Maria Dourron, PhD
Decolonizing the Medicalization of Psychedelics
Christine Hauskeller, PhD
Day 2 – November 16, 2024
8:00-8:05 AM Welcome & Introduction
Franklin King, MD
MODULE TOPIC 5: Neuroscience of Psychedelics
8:05-8:30 AM Simultaneous Imaging of Clinicians and Participants with Fibromyalgia: Perspectives and Results from the MDMA Hyperscan Study
Vitaly Napadow, PhD
8:30-8:55 AM The Effects of Psilocybin on Cognition
Ceyda Sayali, PhD
8:55-9:20 AM Cognitive Neuroscience of Psychedelics
Alfred Kaye, MD, PhD
9:20-9:50 AM Panel Discussion
Moderator: Bruce Rosen, MD, PhD
Panelists: Ceyda Sayali, PhD, Alfred Kaye, MD, PhD,
Vitaly Napadow, PhD
9:50-10:05 AM Break
MODULE TOPIC 6: Ketamine
10:05-10:25 AM Ketamine-Assisted Psychotherapy – Inpatient Treatment of the Future?
Fernando Espi Forcen, MD
10:25-10:50 AM Ketamine and Esketamine for Major Depression
Cristina Cusin, MD
10:50-11:20 AM Panel Discussion
Moderator: Franklin King, MD
Panelists: Cristina Cusin, MD, Fernando Espi Forcen, MD
MODULE TOPIC 7: Clinical Applications of Psychedelics
11:20-11:45 AM Psilocybin-Assisted Therapy for Depression: A Critical Look at the Evidence
Kelley O’Donnell, MD
11:45-12:05 PM Amplifying PTSD Treatments with MDMA
Anne Wagner, PhD
12:05-12:25 PM Psychedelics and Addictions: Psilocybin for Cocaine Use Disorder
Brian Barnett, MD
12:25-12:55 PM Panel Discussion
Moderator: Franklin King, MD
Panelists: Kelley O’Donnell, MD, Anne Wagner, PhD, Brian Barnett, MD
12:55-1:55 PM Lunch Break (on your own)
Ticketed Lunch Workshop – Building a Psychedelic Assisted Therapy Practice
Albert Yeung, MD; Maren Nyer, PhD; Elizabeth Call, PhD; Francis Guerriero, MA, LICSW
MODULE TOPIC 8: Structural and Systemic Issues in Psychedelics
1:55-2:20 PM Challenging Structural Racism in Psychedelic Research
Darron Smith, PhD
2:20-2:45 PM Psychedelics and the Law
Mason Marks, MD, JD
2:45-3:15 PM Panel Discussion
Moderator: Franklin King, MD
Panelists: Mason Marks, MD, JD, Darron Smith, PhD
3:15-3:30 PM Break
MODULE TOPIC 9: Challenges of Implementation
3:30-3:55 PM How to Educate Clinicians on Psychedelics?
Janis Phelps, PhD, Franklin King, MD, Roxanne Sholevar, MD
3:55-4:20 PM Who’s Going to Pay for All This? Challenges of Psychedelic Rollout in
Hospital Psychiatry
Brian Barnett, MD
4:20-4:50 PM Panel Discussion
Moderator – Franklin King, MD
Panelists: Janis Phelps, PhD, Brian Barnett, MD, Roxanne Sholevar, MD
4:50 PM Adjourn
Join us at the Westin Copley Place for The Fourth Annual Conference on Psychedelics and Psychedelic Medicine!
Course Director:
Franklin King, MD
Speakers:
Tristan Angieri, MArch, MTS Candidate
Michael Alpert, MD
Brian Barnett, MD
Yvan Beaussant, MD
Elizabeth Call, PsyD
Cristina Cusin, MD
Rick Doblin, PhD
Haley Dourron, PhD
Fernando Espi Forcen, MD
Francis Guerriero, MA, LICSW
Stephen Haggarty, PhD
Christine Hauskeller, PhD
Alfred Kaye, MD, PhD
Mason Marks, MD, JD
Vitaly Napadow, PhD
Maren Nyer, PhD
Kelley O’Donnell, MD
Janis Phelps, PhD
Alden Doerner Rinaldi, MD
Bruce Rosen, MD, PhD
Jerrold F. Rosenbaum, MD
Ceyda Sayali, PhD
Eduardo Schenberg, PhD
Roxanne Sholevar, MD
Zachary Sager, MD
Darron Smith, PhD
Lisa Summer, PhD
Anne Wagner, PhD
Albert Yeung, MD
Available Credit
- 15.00 AMA PRA Category 1 Credit™
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of McLean Hospital and Massachusetts General Hospital. McLean Hospital is accredited by the ACCME to provide continuing medical education for physicians.
McLean Hospital designates this Live activity for a maximum of 15.00 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- 15.00 Nursing Contact Hours
Massachusetts General Laws, Chapter 13, sections 13, 14, 14A, 15 and 15D and Chapter 112, sections 74 through 81C authorize the Board of Registration in Nursing to regulate nursing practice and education.
This program meets the requirements of the Massachusetts Board of Registration in Nursing (244 CMR 5.00) for 15.00 contact hours of nursing continuing education credit. Advance practice nurses, please note: Educational activities which meet the requirements of the ACCME (such as this activity) count towards 50% of the nursing requirement for ANCC accreditation.
- 15.00 Social Workers
The Collaborative of NASW, Boston College, and Simmons College Schools of Social Work authorizes social work continuing education credits for courses, workshops, and educational programs that meet the criteria outlined in 258 CMR of the Massachusetts Board of Registration of Social Workers
This program has been approved for 15.00 Social Work Continuing Education hours for relicensure, in accordance with 258 CMR. Collaborative of NASW and the Boston College and Simmons Schools of Social Work Authorization Number
- 15.00 Participation
This course allows other providers to claim a Participation Certificate upon successful completion of this course.
Participation Certificates will specify the title, location, type of activity, date of activity, and number of AMA PRA Category 1 Credit™ associated with the activity. Providers should check with their regulatory agencies to determine ways in which AMA PRA Category 1 Credit™ may or may not fulfill continuing education requirements. Providers should also consider saving copies of brochures, agenda, and other supporting documents.
- 15.00 Psychologists CE Credit
The Massachusetts General Hospital Department of Psychiatry is approved by the American Psychological Association to sponsor continuing education for psychologists. The Massachusetts General Hospital Department of Psychiatry maintains responsibility for this program and its content.
This offering meets the criteria for 15.00 Continuing Education (CE) credits per presentation for psychologists.
Price
Accreditation
In support of improving patient care, MGH Institute of Health Professions is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
15.0 Physicians
MGH Institute of Health Professions designates this live activity for a maximum of 15.0 AMA PRA Category 1 Credits ™. Physicians should claim only credit commensurate with the extent of their participation in this activity.
15.0 Nursing Contact Hours
MGH Institute of Health Professions designates this activity for 15.0 contact hours for nurses.
15.0 Social Workers
As a Jointly Accredited Organization, MGH Institute of Health Professions is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. MGH Institute of Health Professions maintains responsibility for this course. Social workers completing this course receive 15.0 clock hours for continuing education credits.
15.0 IPCE Credit
As a Jointly Accredited Organization, MGH Institute of Health Professions is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. MGH Institute of Health Professions maintains responsibility for this course. Social workers completing this course receive 15.0 clock hours for continuing education credits.